Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free HCM Stock Alerts
LON:HCM

HUTCHMED (HCM) Share Price, News & Analysis

HUTCHMED logo
GBX 216 +6.00 (+2.86%)
As of 09/25/2026 12:05 PM Eastern
Compare

About HUTCHMED Stock (LON:HCM)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
207
▼
216
50-Day Range
166.50
▼
217
52-Week Range
150.48
▼
247
Volume
2,846 shs
Average Volume
39,484 shs
Market Capitalization
£1.88 billion
P/E Ratio
108.00
Dividend Yield
4.63%
Price Target
N/A
Consensus Rating
N/A

Company Overview

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).

Receive HCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HUTCHMED and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCM Stock News Headlines

HUTCHMED to showcase pivotal lung cancer and broad oncology data at ESMO 2026
September 23, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/hutchmed-to-showcase-pivotal-lung-cancer-and-broad-oncology-data-at-esmo-2026?utm_source=marketbeat.com&utm_medium=referral
HUTCHMED Announces Multiple ESMO 2026 Presentations, Including Oral Phase III Results for Savolitinib Plus Osimertinib in NSCLC
September 23, 2026  |  quiverquant.comQ
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
September 27 at 1:00 AM  |  Stansberry Research (Ad)
HUTCHMED (LON:HCM) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?
September 19, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31032139
Citi Sticks to Its Buy Rating for HUTCHMED (China) (HCM)
September 6, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HCM/pressreleases/4464902/citi-sticks-to-its-buy-rating-for-hutchmed-china-hcm/
Positive Report for HUTCHMED (China) (HCM) from Daiwa
September 5, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/4464926/positive-report-for-hutchmed-china-hcm-from-daiwa/
Biggest stock movers Thursday: AVGO, SNOW, HPE, and more
September 3, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4639850-biggest-stock-movers-thursday-snow-hpe-and-more
HUTCHMED (China) Limited: HUTCHMED Announces NMPA Approval for ATLED (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
August 28, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69434518-hutchmed-china-limited-hutchmed-announces-nmpa-approval-for-atled-fanregratinib-for-the-treatment-of-patients-with-fgfr2-fusion-rearrangement-int-399.htm
See More Headlines

HCM Stock Analysis - Frequently Asked Questions

HUTCHMED's stock was trading at GBX 209 at the beginning of the year. Since then, HCM shares have increased by 3.3% and is now trading at GBX 216.

Shares of HCM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that HUTCHMED investors own include Associated British Foods (ABF), Chaarat Gold (CGH), Bank of America (BAC), Fossil Group (FOSL), AMC Entertainment (AMC) and Air Canada (AC).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
LON:HCM
CIK
N/A
Web
www.chi-med.com
Phone
+85221213888
Fax
N/A
Employees
1,760
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 2
Trailing P/E Ratio
108.00
Forward P/E Ratio
44.55
P/E Growth
N/A
Net Income
-£52.98 million
Net Margins
163.84%
Pretax Margin
N/A
Return on Equity
36.88%
Return on Assets
-5.90%

Debt

Debt-to-Equity Ratio
7.91
Current Ratio
4.96
Quick Ratio
2.97

Sales & Book Value

Annual Sales
£549.12 million
Price / Sales
3.42
Cash Flow
GBX 86.58 per share
Price / Cash Flow
2.49
Book Value
GBX 87.44 per share
Price / Book
2.47

Miscellaneous

Outstanding Shares
869,071,000
Free Float
N/A
Market Cap
£1.88 billion
Optionable
Not Optionable
Beta
0.43
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (LON:HCM) was last updated on 9/27/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel